By CHASE BRODSKY
Moderna, Pfizer, Johnson & Johnson–people across the country are rushing to receive a dosage of the COVID-19 vaccines. The Jericho community is only a tiny fraction of the millions of individuals who are eagerly waiting their turn to obtain a vaccine to combat COVID-19.
The JerEcho conducted a survey about the vaccine and 52.4% of students who responded reported they would get the vaccine as soon as it becomes available to their age group. Freshman Sydney B. said, “I would take the vaccine, not as soon as it comes out, but I definitely would.”
Another student, freshman Jack K. said, “If it helps me, then I will gladly take it.”
While a majority of Jericho students plan to get the vaccine, many remain unsure.
Among the students who are eager to receive the vaccine, some of the Jericho student body have already had this opportunity. “I think it ran very smoothly,” said Junior Sydney L. “It is a great cushion to have.”
Of the respondents who said they would not get the vaccine, the majority gave as their reason that the vaccine was developed too quickly.
Some students have not yet made a decision either way. Senior Jake S. is uncertain about getting the vaccine. He said, “I’m not sure if I am going to get it because my parents are unsure of how safe and effective it is.”
Many teachers in Jericho have received not only the first, but the second dose of the vaccine. Dance teacher Ms. Corbett has been fully vaccinated and supports the idea of students being inoculated. “I feel that students should receive the vaccine as long as their families and doctors think it is safe,” said Ms. Corbett.
Dr. Donald Palmadessa, a gastroenterologist practicing in Douglaston, NY, is a vocal advocate for the vaccine. He hopes for his patients to get the vaccine when they qualify for it. “I strongly encourage everyone to take the vaccine,” said Dr. Palmadessa.
Dr. Palmadessa tries to help his patients overcome vaccine hesitancy with facts and information.
While Dr. Palmadessa understands some patients’ reluctance to receive this new vaccine, he said, “I must provide my patients with the scientific data in a way that they can understand so that they make an informed decision on whether to receive or reject the vaccine.”
Now that the vaccine is available for all New York residents over the age of 16, it will be interesting to see how many Jericho students get vaccinated in the coming months.